Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration

被引：0
作者：
Qingke Chen
Lingmin Fu
Jieping Hu
Guanghua Guo
An Xie
机构：
[1] First Affiliated Hospital of Nanchang University,Department of Urology
[2] First Affiliated Hospital of Nanchang University,Institute of Urology
[3] First Affiliated Hospital of Nanchang University,Department of Burns
[4] Jiangxi Health Vocational College,undefined
来源：
Cancer Cell International | / 21卷
关键词：
Prostate cancer; PSMC2; Cell proliferation; Cell apoptosis; Akt pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 92 条
  • [1] Gasnier A(2017)Updates on the diagnosis and treatment of prostate cancer Brit J Radiol 90 20170180-424
  • [2] Parvizi N(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA-Cancer J Clin 68 394-34
  • [3] Bray F(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-30
  • [4] Siegel RL(2018)Cancer statistics, 2018 CA-Cancer J Clin 68 7-357
  • [5] Miller KD(2018)The surgical management of prostate Cancer Semin Oncol 44 347-490
  • [6] Jemal A(2016)Diagnostic and therapeutic strategies for prostate cancer Semin Nucl Med 46 484-327
  • [7] Siegel RL(2000)Clinical states in prostate cancer: toward a dynamic model of disease progression ☆ Urology 55 323-1323
  • [8] Miller KD(2012)Overcoming drug resistance and treating advanced prostate cancer Curr Drug Targets. 13 1308-1095
  • [9] Jemal A(2017)The evolving role of chemotherapy in prostate cancer Future Oncol 13 1091-143
  • [10] Sebesta EM(2016)Systematic review: does endocrine therapy prolong survival in patients with prostate cancer? Scand J Urol 50 135-374
12345678910